通过多组学分析对卵巢高度血清/子宫内膜癌的分子分类:JGOG3025-TR2研究
Shiro Takamatsu1,2,3, R Tyler Hillman2,3,4, Kosuke Yoshihara5
1Department of Gynecology and Obstetrics, Kyoto University Graduate School of Medicine, Kyoto, Japan.
British journal of cancer
|August 30, 2024
概括
卵巢高度子宫内膜癌 (HGEC) 类型的瘤,在高度血清癌 (HGSC) 诊断中确定,显示出良好的预后和子宫内膜分化,而不是同源重组缺陷 (HRD). 这些发现有助于区分HGEC和HGSC.
科学领域:
- 妇科瘤学 妇科瘤学
- 癌症基因组学 癌症基因组学
- 分子病理学分子病理学
背景情况:
- 卵巢高度子宫内膜癌 (HGEC) 和高度血清癌 (HGSC) 之间的组织病理相似性导致诊断变异.
- 同源重组缺陷 (HRD) 与HGSC中的药物敏感性有关,但HGEC的分子特征仍然不清楚.
研究的目的:
- 在HGSC诊断中以HGEC特征对卵巢瘤进行分子特征.
- 在HGSC中识别不同的分子亚型及其临床含义.
主要方法:
- 向DNA测序,RNA测序,DNA甲基化阵列和SNP阵列在卵巢HGEC和HGSC样本上进行.
- 基于副本编号签名的无监督聚类被用来分组瘤.
- 分析包括来自JGOG-TR2,TCGA-OV和TCGA-UCEC的队列.
主要成果:
- 确定了四个瘤组 (C1-C4). 称为"HGEC型"的C4瘤显示出良好的结局,较高的HGEC比例,较低的HRD得分,以及正常的子宫内膜样DNA甲基化概况.
- 在HGEC型瘤中,缺乏BRCA1/2变异和CCNE1放大.
- 这些HGEC类型的瘤也在TCGA-OV和TCGA-UCEC数据集中被发现.
结论:
- 卵巢"HGEC型"瘤在HGSC诊断中代表了一个独特的分子亚型.
- "HGEC型"瘤的特点是非HRD状态,良好的预后和子宫内膜分化.
- 这些发现表明,临床诊断的HGSCs的一个子集的潜在重新分类.
更多相关视频
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
6.7K
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
2.6K
相关概念视频
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
